FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024421037> ?p ?o ?g. }

• W2024421037 endingPage "2620" @default.
• W2024421037 startingPage "2615" @default.
• W2024421037 abstract "ObjectiveTo investigate the effect of mifepristone on peripheral blood natural killer cell's (pbNK) cytotoxicity and the expression of the inhibitory receptor CD94/NKG2A and the activated receptor NKG2D on pbNK cells.DesignIn vitro study.SettingUniversity hospital and research laboratory.Patient(s)Twenty healthy nonpregnant women.Intervention(s)Detected the cytolytic activity of pbNK to K562 target cells; measured the expression of CD94/NKG2A and NKG2D on pbNK.Main Outcome Measure(s)Cytotoxicity of pbNK was detected by Methyl thiazolyl tetrazolium. The expression of CD94/NKG2A and NKG2D receptor on pbNK cells were detected by flow cytometry.Result(s)The NK cell cytotoxicity and the expression of inhibitory receptor CD94/NKG2A during the proliferative phase (81.71 ± 11.5, 86.6 ± 9.0) was significantly higher than the secretory phase (60.16 ± 19.2, 60.15 ± 31.0). The NK cells cytotoxicity, after being treated with mifepristone and the expression of inhibitory receptor CD94/NKG2A on pbNK cells treated with 200 nmol/L mifepristone, were significantly increased. Mifepristone had no effect on the expression of activating receptor NKG2D.Conclusion(s)These data suggest that Mifepristone maybe exert its anti-implantation function by increasing NK cytotoxicity. The increasing NK cytotoxicity of mifepristone is not related to CD94/NKG2A and NKG2D. In the secretory phase down-regulated CD94/NKG2A, NKG2D, and NK cytotoxicity may benefit with embryo implantation. To investigate the effect of mifepristone on peripheral blood natural killer cell's (pbNK) cytotoxicity and the expression of the inhibitory receptor CD94/NKG2A and the activated receptor NKG2D on pbNK cells. In vitro study. University hospital and research laboratory. Twenty healthy nonpregnant women. Detected the cytolytic activity of pbNK to K562 target cells; measured the expression of CD94/NKG2A and NKG2D on pbNK. Cytotoxicity of pbNK was detected by Methyl thiazolyl tetrazolium. The expression of CD94/NKG2A and NKG2D receptor on pbNK cells were detected by flow cytometry. The NK cell cytotoxicity and the expression of inhibitory receptor CD94/NKG2A during the proliferative phase (81.71 ± 11.5, 86.6 ± 9.0) was significantly higher than the secretory phase (60.16 ± 19.2, 60.15 ± 31.0). The NK cells cytotoxicity, after being treated with mifepristone and the expression of inhibitory receptor CD94/NKG2A on pbNK cells treated with 200 nmol/L mifepristone, were significantly increased. Mifepristone had no effect on the expression of activating receptor NKG2D. These data suggest that Mifepristone maybe exert its anti-implantation function by increasing NK cytotoxicity. The increasing NK cytotoxicity of mifepristone is not related to CD94/NKG2A and NKG2D. In the secretory phase down-regulated CD94/NKG2A, NKG2D, and NK cytotoxicity may benefit with embryo implantation." @default.
• W2024421037 created "2016-06-24" @default.
• W2024421037 creator A5024933588 @default.
• W2024421037 creator A5027475930 @default.
• W2024421037 creator A5063549313 @default.
• W2024421037 creator A5073492646 @default.
• W2024421037 creator A5086939900 @default.
• W2024421037 date "2010-05-01" @default.
• W2024421037 modified "2023-10-16" @default.
• W2024421037 title "The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase" @default.
• W2024421037 cites W1572727383 @default.
• W2024421037 cites W1934719640 @default.
• W2024421037 cites W1946216897 @default.
• W2024421037 cites W1974916123 @default.
• W2024421037 cites W1982488750 @default.
• W2024421037 cites W1986411025 @default.
• W2024421037 cites W1996968534 @default.
• W2024421037 cites W1997306559 @default.
• W2024421037 cites W1999782096 @default.
• W2024421037 cites W2008193794 @default.
• W2024421037 cites W2009617027 @default.
• W2024421037 cites W2017759565 @default.
• W2024421037 cites W2023086378 @default.
• W2024421037 cites W2024156210 @default.
• W2024421037 cites W2027140056 @default.
• W2024421037 cites W2040355823 @default.
• W2024421037 cites W2041235830 @default.
• W2024421037 cites W2048482821 @default.
• W2024421037 cites W2053948715 @default.
• W2024421037 cites W2055182412 @default.
• W2024421037 cites W2062951761 @default.
• W2024421037 cites W2067885045 @default.
• W2024421037 cites W2081204410 @default.
• W2024421037 cites W2085818294 @default.
• W2024421037 cites W2087128527 @default.
• W2024421037 cites W2090712553 @default.
• W2024421037 cites W2096483577 @default.
• W2024421037 cites W2107553959 @default.
• W2024421037 cites W2130649175 @default.
• W2024421037 cites W2159699644 @default.
• W2024421037 cites W2160072698 @default.
• W2024421037 cites W2161760518 @default.
• W2024421037 cites W2164294092 @default.
• W2024421037 cites W2171709048 @default.
• W2024421037 cites W39910466 @default.
• W2024421037 cites W4252553635 @default.
• W2024421037 cites W4367478616 @default.
• W2024421037 cites W56372810 @default.
• W2024421037 doi "https://doi.org/10.1016/j.fertnstert.2009.09.015" @default.
• W2024421037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19880106" @default.
• W2024421037 hasPublicationYear "2010" @default.
• W2024421037 type Work @default.
• W2024421037 sameAs 2024421037 @default.
• W2024421037 citedByCount "10" @default.
• W2024421037 countsByYear W20244210372012 @default.
• W2024421037 countsByYear W20244210372013 @default.
• W2024421037 countsByYear W20244210372014 @default.
• W2024421037 countsByYear W20244210372015 @default.
• W2024421037 countsByYear W20244210372018 @default.
• W2024421037 countsByYear W20244210372021 @default.
• W2024421037 crossrefType "journal-article" @default.
• W2024421037 hasAuthorship W2024421037A5024933588 @default.
• W2024421037 hasAuthorship W2024421037A5027475930 @default.
• W2024421037 hasAuthorship W2024421037A5063549313 @default.
• W2024421037 hasAuthorship W2024421037A5073492646 @default.
• W2024421037 hasAuthorship W2024421037A5086939900 @default.
• W2024421037 hasBestOaLocation W20244210371 @default.
• W2024421037 hasConcept C109316439 @default.
• W2024421037 hasConcept C149532602 @default.
• W2024421037 hasConcept C154317977 @default.
• W2024421037 hasConcept C170493617 @default.
• W2024421037 hasConcept C185592680 @default.
• W2024421037 hasConcept C202751555 @default.
• W2024421037 hasConcept C203014093 @default.
• W2024421037 hasConcept C2778102761 @default.
• W2024421037 hasConcept C2778826759 @default.
• W2024421037 hasConcept C2778867473 @default.
• W2024421037 hasConcept C2779234561 @default.
• W2024421037 hasConcept C28651165 @default.
• W2024421037 hasConcept C54355233 @default.
• W2024421037 hasConcept C553184892 @default.
• W2024421037 hasConcept C55493867 @default.
• W2024421037 hasConcept C86803240 @default.
• W2024421037 hasConceptScore W2024421037C109316439 @default.
• W2024421037 hasConceptScore W2024421037C149532602 @default.
• W2024421037 hasConceptScore W2024421037C154317977 @default.
• W2024421037 hasConceptScore W2024421037C170493617 @default.
• W2024421037 hasConceptScore W2024421037C185592680 @default.
• W2024421037 hasConceptScore W2024421037C202751555 @default.
• W2024421037 hasConceptScore W2024421037C203014093 @default.
• W2024421037 hasConceptScore W2024421037C2778102761 @default.
• W2024421037 hasConceptScore W2024421037C2778826759 @default.
• W2024421037 hasConceptScore W2024421037C2778867473 @default.
• W2024421037 hasConceptScore W2024421037C2779234561 @default.
• W2024421037 hasConceptScore W2024421037C28651165 @default.
• W2024421037 hasConceptScore W2024421037C54355233 @default.
• W2024421037 hasConceptScore W2024421037C553184892 @default.
• W2024421037 hasConceptScore W2024421037C55493867 @default.

• next